Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johansson, B. B.
Right arrow Articles by Linder, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johansson, B. B.
Right arrow Articles by Linder, L. E.

Stroke, Vol 13, 220-225, Copyright © 1982 by American Heart Association


ARTICLES

Phenothiazine-mediated protection of the blood-brain barrier during acute hypertension

BB Johansson, LM Auer and LE Linder

The phenothiazine dixyrazine (5 mg . kg-1 i.v.) had minimal, transient hypotensive effects but significantly reduced the leakage of 125I labelled serum albumin in conscious rats subjected to acute hypertension provoked by i.v. adrenaline or bicuculline. By contrast, dixyrazine did not protect the blood-brain barrier during osmotic stress induced by intracarotid infusion of 2 M urea. The diameters of pial arteries and veins were continuously measured with a multichannel videoangiometer through a closed cranial window in anesthetized rats before and after i.v. injection of dixyrazine (5 mg . kg-1). No change in vessel diameter was observed except for a transient autoregulatory dilatation of arteries in response to a slight transitory decrease in the blood pressure. It is concluded that dixyrazine probably protects the blood-brain barrier during mechanical stress by modifying the endothelial cell membrane.